Work

140-LB: NGM313, a Novel Activator of b-Klotho/FGFR1c, Improves Insulin Resistance and Reduces Hepatic Fat in Obese, Nondiabetic Subjects

Year: 2019

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Diabetes

DOI: 10.2337/db19-140-lb

Authors: ALEX DEPAOLI, VAN PHUNG, MUSTAFA R. BASHIR, LINDA MORROW, CARINE BEYSEN, ANDREW YAN, LEI LING, BRYAN BAXTER, KENNETH L. LUSKEY, JERROLD M. OLEFSKY

Language: English

Topic: Fibroblast Growth Factor Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2948900613

FWCI: 1.026

Cites:

Cited by: 28

Related to: 10